BioLine RX Balance Sheet Statement

BLRX $3.09 -0.1 -4.3%

26/02/21

Adventurous, Small Cap, Momentum Trap

Market Cap £94.2m

Enterprise Value £83.5m

Revenue £n/a

Quality

Value

Momentum

StockRank™

To unlock BioLine RX's balance sheet statement please upgrade your membership.

	2015	2016	2017	2018	2019	2020
Period End:	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31
Period Length:	0	0	0	0	0	0
Currency:	USD	USD	USD	USD	USD	USD

Cash
Cash & Equivalents
Short Term Investments
Cash and Short Term Investments
Total Receivables, Net
Prepaid Expenses
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Intangibles, Net
Long Term Investments
Other Long Term Assets, Total
Total Assets

Accounts Payable
Payable/Accrued
Accrued Expenses
Notes Payable/Short Term Debt
Current Port. of LT Debt/Capital Leases
Other Current Liabilities, Total
Total Current Liabilities

Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Other Liabilities, Total
Total Liabilities

Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Other Equity, Total
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.